NCT06906770

Virtual Reality-based Eye Movement Desensitisation and Reprocessing Therapy for Specific Phobias

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: The University of Northampton · Academic / Other
• Sex: All
• Age: 17 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to study the effectiveness of a virtual reality-based eye movement desensitization and reprocessing (EMDR) application in treating phobia. It will also learn about the feasibility and safety of the application for independent use. The main questions it aims to answer are: Does the VR EMDR application reduce distress, improve positive cognitions, and decrease avoidance of specific phobias? Can the application help diminish phobia-related bodily sensations and encourage cognitive shifts toward positive beliefs and greater confidence in confronting previously avoided situations? Can the participants independently administer the treatment with minimum assistance? Participants will: Visit the site and take the VR EMDR phobia treatment every day for one week. Report their phobia and simulator sickness symptoms through self-report questionnaires or semi-structured interviews.

Conditions

• Specific Phobias

Interventions

Type	Name	Description
OTHER	Eye movement desensitization and reprocessing phobia treatment in virtual reality	Short form and frequent eye movement desensitization and reprocessing (EMDR) in virtual reality for specific phobia treatment.

Timeline

• Start date: 2025-04-28
• Primary completion: 2025-05-02
• Completion: 2025-05-02
• First posted: 2025-04-02
• Last updated: 2025-05-28

Locations

1 site across 1 country: United Kingdom